Optimum Nutrition
1
/
of
8
NusaPure Dong Quai with Angelica Sinensis Root 100mg Extract 20:1 - Suitable for Vegetarian/Vegan, Non- GMO - 2000 mg - 150 Capsules
NusaPure Dong Quai with Angelica Sinensis Root 100mg Extract 20:1 - Suitable for Vegetarian/Vegan, Non- GMO - 2000 mg - 150 Capsules
No reviews
No reviews
Regular price
$15.99 USD
Regular price
Sale price
$15.99 USD
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
The full picture
Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →
42/100
Rejected
Six-dimension breakdown
Evidence
35
Formulation
45
Manufacturing
50
Safety
38
Transparency
45
Sustainability
50
Why this scored 42/100
NusaPure Dong Quai (Angelica sinensis) at a 20:1 extract 100 mg per capsule (marketed as 2000 mg raw equivalent). Dong quai is a traditional Chinese medicine herb used for menstrual and menopausal support. The published RCT evidence is limited and largely negative: Hirata 1997 (Fertil Steril) tested dong quai 4.5 g/day vs placebo in postmenopausal women and found NO benefit for hot flashes, vaginal maturation, or endometrial thickness. Documented safety concerns are substantial: dong quai contains furanocoumarins that cause photosensitization (Yun 2015); it has anticoagulant activity that potentiates warfarin (Page 1999, Ellis 2002 documented INR increases and bleeding events); it is a uterine stimulant contraindicated in pregnancy; and it may have estrogenic activity concerning for hormone-sensitive cancer history. The combination of thin efficacy evidence and multiple documented safety concerns places it firmly in Rejected under safety_concern.
Last scored: Full rubric →
Evidence & sources
The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.
Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.
How to read the Evidence dimension
- 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
- 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
- 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
- 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
- 0–19: No credible evidence base or unverifiable claims.
FAQ data has not been generated for this product yet. See the site FAQ for general questions.
Customer reviews
Reviews on other platforms
The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.
All the data we have on this product
Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.
- VSF score
- 42 / 100
- Tier
- Rejected
- Category
- Supplements
- Subcategory
- womens health
- Last scored
- Third-party certifications
- None on record at time of scoring
- Vendor
- NusaPure
- Tags
- NusaPure, Shopify Collective
Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.
Share
